PREEMPT Act

The PREEMPT Act amends the Social Security Act to require the Secretary of Health and Human Services to issue guidance to states on which tests for screening and early detection of preeclampsia may be covered under Medicaid and the Children's Health Insurance Program.

Sec. 3, Guidance on Medicaid coverage of preeclampsia screening and detection tests: Within 180 days of enactment, the Secretary must issue guidance to states and managed care organizations on best practices for improving outcomes for pregnant women with preeclampsia through early screening, detection, and management, and on which tests for early detection may be furnished as medical assistance, including whether biomarker tests may be covered. The Secretary must provide technical assistance to states within 30 days of a request regarding coverage of specific tests, but states are not required to request such assistance as a condition of providing coverage or receiving federal funding. The Secretary must consider advanced biomarker tests for early detection of preeclampsia, including those cleared under the Federal Food, Drug, and Cosmetic Act as devices and laboratory-developed testing services from certified high-complexity clinical laboratories.